Viewing Study NCT04422366


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2025-12-25 @ 2:04 PM
Study NCT ID: NCT04422366
Status: RECRUITING
Last Update Posted: 2024-06-07
First Post: 2020-05-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Sponsor: Shanghai Bovax Biotechnology Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 9-HPV-3001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators